| Nivolumab plus ipilimumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial N Dizman, L Meza, P Bergerot, M Alcantara, T Dorff, Y Lyou, P Frankel, ... Nature medicine 28 (4), 704-712, 2022 | 225 | 2022 |
| Stool microbiome profiling of patients with metastatic renal cell carcinoma receiving anti–PD-1 immune checkpoint inhibitors NJ Salgia, PG Bergerot, MC Maia, N Dizman, JA Hsu, JD Gillece, ... European urology 78 (4), 498-502, 2020 | 129 | 2020 |
| Cabozantinib in combination with immunotherapy for advanced renal cell carcinoma and urothelial carcinoma: rationale and clinical evidence P Bergerot, P Lamb, E Wang, SK Pal Molecular cancer therapeutics 18 (12), 2185-2193, 2019 | 94 | 2019 |
| Responses to alectinib in ALK-rearranged papillary renal cell carcinoma SK Pal, P Bergerot, N Dizman, C Bergerot, J Adashek, R Madison, ... Eur Urol 74 (1), 124-128, 2018 | 69 | 2018 |
| A phase 1 trial of SGN‐CD70A in patients with CD70‐positive, metastatic renal cell carcinoma SK Pal, A Forero‐Torres, JA Thompson, JC Morris, S Chhabra, ... Cancer 125 (7), 1124-1132, 2019 | 47 | 2019 |
| Association of circulating tumor DNA (ctDNA) detection in metastatic renal cell carcinoma (mRCC) with tumor burden MC Maia, PG Bergerot, N Dizman, JA Hsu, J Jones, RB Lanman, ... Kidney Cancer 1 (1), 65-70, 2017 | 43 | 2017 |
| Randomized trial assessing impact of probiotic supplementation on gut microbiome and clinical outcome from targeted therapy in metastatic renal cell carcinoma N Dizman, JA Hsu, PG Bergerot, JD Gillece, M Folkerts, L Reining, J Trent, ... Cancer Medicine 10 (1), 79-86, 2021 | 42 | 2021 |
| The role of circulating tumor DNA in renal cell carcinoma PG Bergerot, AW Hahn, CD Bergerot, J Jones, SK Pal Current treatment options in oncology 19, 1-11, 2018 | 40 | 2018 |
| Fear of cancer recurrence or progression: what is it and what can we do about it? CD Bergerot, EJ Philip, PG Bergerot, N Siddiq, S Tinianov, M Lustberg American Society of Clinical Oncology Educational Book 42, 18-27, 2022 | 34 | 2022 |
| Correlates of clinical benefit from immunotherapy and targeted therapy in metastatic renal cell carcinoma: comprehensive genomic and transcriptomic analysis N Dizman, Y Lyou, N Salgia, PG Bergerot, JA Hsu, D Enriquez, T Izatt, ... Journal for immunotherapy of cancer 8 (2), 2020 | 34 | 2020 |
| Assessment of distress and quality of life in rare cancers CD Bergerot, PG Bergerot, EJ Philip, EBL De Domenico, MFM Manhaes, ... Psycho‐Oncology 27 (12), 2740-2746, 2018 | 32 | 2018 |
| The changing landscape of management of metastatic renal cell carcinoma: current treatment options and future directions NJ Salgia, Y Dara, P Bergerot, M Salgia, SK Pal Current Treatment Options in Oncology 20, 1-8, 2019 | 31 | 2019 |
| Examining public communication about kidney cancer on Twitter MS Sedrak, MM Salgia, C Decat Bergerot, K Ashing-Giwa, BN Cotta, ... JCO Clinical Cancer Informatics 3, 1-6, 2019 | 30 | 2019 |
| Circulating cytokines associated with clinical response to systemic therapy in metastatic renal cell carcinoma A Chehrazi-Raffle, L Meza, M Alcantara, N Dizman, P Bergerot, N Salgia, ... Journal for Immunotherapy of Cancer 9 (3), 2021 | 27 | 2021 |
| Discrepancies between genitourinary cancer patients' and clinicians' characterization of the Eastern Cooperative Oncology Group performance status CD Bergerot, EJ Philip, PG Bergerot, JA Hsu, N Dizman, M Salgia, ... Cancer 127 (3), 354-358, 2021 | 26 | 2021 |
| Perception of cure among patients with metastatic genitourinary cancer initiating immunotherapy CD Bergerot, PG Bergerot, EJ Philip, JA Hsu, N Dizman, U Vaishampayan, ... Journal for ImmunoTherapy of Cancer 7, 1-5, 2019 | 24 | 2019 |
| Relationship of tumor mutational burden (TMB) to immunotherapy response in metastatic renal cell carcinoma (mRCC). MC Maia, L Almeida, PG Bergerot, N Dizman, SK Pal Journal of Clinical Oncology 36 (6_suppl), 662-662, 2018 | 22 | 2018 |
| Assessment of treatment patterns for metastatic renal cell carcinoma in Brazil PG Bergerot, CD Bergerot, N Dizman, S Zequi, A Fay, Y Dara, MC Maia, ... Journal of global oncology 4, 1-8, 2017 | 22 | 2017 |
| Fear of cancer recurrence in patients with localized renal cell carcinoma CD Bergerot, D Battle, EJ Philip, PG Bergerot, P Msaouel, AB Smith, ... JCO Oncology Practice 16 (11), e1264-e1271, 2020 | 21 | 2020 |
| Distress and quality of life among patients with advanced genitourinary cancers CD Bergerot, EJ Philip, PG Bergerot, SK Pal European urology focus 6 (6), 1150-1154, 2020 | 19 | 2020 |
